Country: South Africa
Language: English
Source: South African Health Products Regulatory Authority (SAHPRA)
Schering
CREON CAPSULES SCHEDULING STATUS: S1 PROPRIETARY NAME (and dosage form): CREON CAPSULES COMPOSITION Per capsule: pancreatin 300 mg. The enzyme activities per capsule are: Amylase : 9000 FIP units* Lipase : 8000 FIP units Protease : 450 FIP units * FIP = Fédération Internationale Pharmaceutique PHARMACOLOGICAL CLASSIFICATION A. 11.1 Digestants. PHARMACOLOGICAL ACTION Creon (pancreatin) substitutes pancreatic enzymes if they are deficient. The capsule dissolves rapidly in the stomach releasing pellets, ie the granulated form of pancreatin. The enzymes are micro-encapsulated in the pellets, the stability of which is set at pH 5,5 so that the enzymes are not inactivated in the stomach. In the duodenum the enzymes become dispersed and digest fats, proteins and carbohydrates. INDICATIONS Supplement for pancreatic exocrine insufficiency which may be caused by: - chronic pancreatitis - cystic fibrosis - partial pancreatectomy CONTRA-INDICATIONS Pancreatic preparations are contra-indicated in the early stages of acute pancreatitis due to the fact that patients are not allowed to eat for the first two to three days. DOSAGE AND DIRECTIONS FOR USE One Creon capsule should be taken three times a day with liquid during main meals. If necessary, the dosage can be increased. The capsule should be swallowed whole, without chewing. Alternatively the capsule may be opened and the pellets administered without the shell from a spoon. The pellets should not be chewed. SIDE EFFECTS AND SPECIAL PRECAUTIONS The following side effects may occur: - Allergy to pancreatin which includes symptoms like sneezing, lachrymation or skin rashes; - Hyperuricosuria and hyperuricaemia with high doses; - Oral and peri-anal soreness. Safety of Read the complete document